Contract facts
FederalNo full NAICS 621511 intel page yet. Browse NAICS intelligence
FY 2026 LAB TESTING FOR CLINICAL LAB AND TISSUE PATHOLOGY is a federal award for Fmc Carswell held by Quest Diagnostics Inc. Estimated value $187K ($63K obligated). Current period of performance ends Sep 30, 2026. Place of performance: SECAUCUS NJ.
FY 2026 LAB TESTING FOR CLINICAL LAB AND TISSUE PATHOLOGY
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordQuest Diagnostics Inc — $202.6M obligated across 1,625 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 15B50526F00000113?
15B50526F00000113 (FY 2026 LAB testing for clinical) is a Fmc Carswell award with a potential value of $187K, currently held by Quest Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 15B50526F00000113?
Fmc Carswell awarded 15B50526F00000113 to Quest Diagnostics Inc (potential $187K).
Who is the incumbent on 15B50526F00000113?
Quest Diagnostics Inc is the incumbent with $202.6M across 1625 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Quest Diagnostics Inc’s 15B50526F00000113 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
